Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Hydrolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1041785A details enzymatic resolution for high-purity chiral esters. This report analyzes supply chain stability and cost reduction in API intermediate manufacturing.
Patent CN101613666B details a novel Bacillus sp. ECU0015 strain for high-purity chiral diol production, offering significant cost reduction and supply chain reliability for pharma intermediates.
Novel biocatalytic resolution method for high-purity dextro-cis-chrysanthemic acid. Simplifies production, reduces costs, and ensures supply chain stability for pyrethroid manufacturers.
Patent CN101701222B reveals a robust enzymatic route for (R)-mandelic acid, offering superior purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN114686465A reveals a hydrolase method for (R)-3-(carbamoylmethyl)-5-methylhexanoic acid, offering green, high-yield production for reliable supply chains.
Patent CN101289456B details enzymatic hydrolysis for higher yield and stability. Offers cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN112625086A reveals a high-purity enzymatic route for Argatroban Impurity G. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN1216858C details enzymatic synthesis of CNS drug intermediates. Offers high optical purity and streamlined manufacturing for reliable pharmaceutical intermediate suppliers.
Patent CN1269950C details a novel biotechnological process for preparing amides using Amycolatopsis and Rhodococcus strains, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1220695A details a microbial process for chiral aminoalcohols, offering a scalable alternative to chemical synthesis for carbocyclic nucleosides.
Patent CN1916164A reveals high-yield hydantoinase method. Reduces cost in API manufacturing. Reliable pharmaceutical intermediate supplier for D-amino acids.
Patent CN1224697C reveals a novel microbial process for high-purity aminoalcohols, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN102277322A details a green enzymatic route for IDA production, offering lower costs and reduced waste compared to traditional chemical hydrolysis methods.
Patent CN120796399A reveals a high-yield enzymatic route for this chiral intermediate. Discover cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN1045297C details enzymatic deprotection for cephalosporin synthesis. Achieve high-purity intermediates with reduced costs and scalable aqueous processes for global supply chains.
Patent CN106978368B details a novel nitrilase biocatalysis route for L-glufosinate precursors, offering high optical purity and reduced environmental impact for agrochemical manufacturing.
Patent CN116396950B reveals novel carboxylesterase mutants for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Patent CN108546720B reveals a green lipase-catalyzed route for Indobufen intermediates, offering high optical purity and reduced environmental impact for pharmaceutical manufacturing.
Patent CN121472200A reveals high-efficiency nitrilase mutant for chiral acid synthesis. Offers green manufacturing and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN103998618A reveals enzymatic hydrolysis for high-purity chiral intermediates. Discover supply chain advantages and cost reduction strategies.